Dr. Malcolm Moore is the President of BC Cancer Agency. He oversees a comprehensive Cancer Control Program including prevention, screening, diagnosis, treatment and supportive care for the five million citizens of British Columbia.
Dr. Moore is also a practicing medical oncologist and researcher and clinical pharmacologist involved in drug development work for cancer therapy. He continues to have a clinical practice in gastrointestinal (GI) oncology in addition to his administrative duties. Prior to his appointment as President of BC Cancer Agency, Dr. Moore was Director of the Drug Development Program and Co-Director of the McCain Centre for Pancreatic Cancer at Princess Margaret Hospital in Toronto. He is also the past President of the International Society of Gastrointestinal Oncology. Over the past two decades, Dr. Moore has been involved in the development of new cancer therapies, has been a principal investigator in a number of practice changing clinical studies, has authored over 250 peer-reviewed publications and has given more than 200 invited lectures worldwide.
Dr. François Bénard is Vice President of Research at BC Cancer Agency. He is responsible for setting and facilitating a comprehensive cancer research strategy and agenda for British Columbia in collaboration with research leadership provincially, nationally and internationally
Dr. Bénard is an international leader in molecular imaging as well as an important part of the research community in British Columbia. His interests combine state-of-the art clinical care with a thriving translational research program in imaging and radionuclide therapy. After leading a highly successful molecular imaging program in Sherbrooke, Québec, he relocated to British Columbia in 2008, where he was awarded the BC Leadership Chair in Functional Cancer Imaging. He became Head of the Division of Nuclear Medicine at the University of British Columbia and Scientific Director of Functional Imaging at the BC Cancer Agency. Under his leadership, his team designed and built a new cyclotron and imaging facility, implemented a comprehensive preclinical imaging platform, set up research radiochemistry and radiopharmacology laboratories and expanded the clinical program. Dr. Bénard has also been highly successful in raising peer-reviewed funding to support the program, recently receiving a Canadian Institutes of Health Research Foundation Scheme grant totaling $1.4 million for the development of new radiopharmaceuticals for cancer diagnosis and therapy. Dr. Bénard has earned numerous prestigious awards over the years, including most recently the 2015 Brockhouse Canada Prize for Interdisciplinary Research in Science and Engineering.
Dr. John Spinelli is Vice President of Population Oncology at BC Cancer Agency. He leads and manages population health services and research to support province-wide cancer control, including the three provincial screening programs, surveillance, prevention, research informatics, indigenous cancer care and cancer control research.
Dr. Spinelli is also a Distinguished Scientist and Head of Cancer Control Research at the BC Cancer Agency, Professor at the School of Population and Public Health at the University of British Columbia and Adjunct Professor in the Department of Statistics and Actuarial Science at Simon Fraser University. Until recently he was the Principal Investigator for the BC Generations Project, part of the Canadian Partnership for Tomorrow Project — the largest health study ever undertaken in Canada; he now serves as the BC Cancer Agency Representative on the Strategic Advisory Council. He is a member of the Data Stewards Working Group at Population Data BC and has served on the University of British Columbia/BC Cancer Agency Research Ethics Board since its inception in 2004. He is a past Chair of both the International Lymphoma Epidemiology Consortium (Interlymph) and the International Multiple Myeloma Consortium and has served on the Board of Directors of the Statistical Society of Canada and the Canadian Society of Epidemiology and Biostatistics. He is currently the Canadian Representative on the Scientific Council of the International Agency for Research on Cancer, and is the author of over 250 peer reviewed publications.
Dr. Lee Ann Martin is Acting Vice President, Clinical Programs & Quality at BC Cancer Agency. She is responsible for the management of the Agency’s clinical vision, including professional practice, clinical quality and performance, safety and regional medical operations, as well as overseeing its business strategy and the development of a comprehensive cancer control strategy for the province.
Dr. Martin completed her MD at the University of Ottawa and Medical Oncology at the University of Calgary after training as a physiologist/psychologist and working within rehab teams in Pain Management. She previously served as Regional Professional Practice Leader of BC Cancer Agency Fraser Valley Centre, and Abbotsford Centre prior to and after its opening in 2008. She has also held leadership positions within Fraser Health Authority. Dr. Martin served as Vice-Chair of the University of British Columbia/BC Cancer Agency Research Ethics Board and has extensive experience in Clinical Trials. Dr. Martin has held or co-held many large peer-reviewed research grants in the areas of quality and health service delivery. These projects have included the creation of two Breast Health Centres within the Fraser Health Authority, implementation of a regionalized febrile neutropenia protocol, development of a regionalized chemotherapy-induced diarrhea protocol and a participatory action research project examining solutions to moral distress and moral climate within the interdisciplinary cancer care team. She is a recent graduate of the Fraser Health Authority Physician Quality and Regional Safety Team initiative, a collaborative physician learning and Quality Insurance research group funded by the Doctors of BC Physician Engagement initiative.
Stephanie Aldridge is Executive Director, Cancer Strategy and Capital Redevelopment at BC Cancer Agency. She enables and facilitates the development, delivery and ongoing management of the organization’s overall strategic, capital and business plans to provide timely, appropriate, equitable and cost-effective health care for people living with or affected by cancer throughout the province.
Ms. Aldridge completed her Radiation Therapy training in 1996 at the Vancouver Centre and has since practiced in British Columbia, Saskatchewan and New Zealand. During this time she pursued her passion for teaching, working as an Instructor at the BC Cancer Agency and British Columbia Institute of Technology and completed her Master’s in Educational Leadership from Simon Fraser University. Ms. Aldridge has worked at the BC Cancer Agency Fraser Valley Centre as Regional Professional Practice Leader, Radiation Therapy, Director of Clinical Operations, Radiation Therapy, and eventually assumed responsibility for Systemic Therapy and Regional Operations. She is Lean Leader certified and in 2015 was honoured with the Innovative Leadership award from the BC Association of Medical Radiation Technologists.
Brenda Canitz is Acting Vice President of Patient Experience and Interprofessional Practice at BC Cancer Agency. She leads interprofessional practice, patient engagement and education and survivorship programs, and is also responsible for professional practice leadership for nurses, psychological services, nutrition, rehabilitation and spiritual care.
Ms. Canitz has held senior nursing leadership positions with Health Canada and the BC Ministry of Health (Chief Nursing Executive and Executive Director for Clinical Care and Patient Safety) and Associate Executive Director for Nursing Services in First Nations and Inuit Health, Health Canada in Ottawa. Ms. Canitz is Adjunct Faculty at the University of Victoria and teaches part time in the School of Public Health and Social Policy. Ms. Canitz has many years of experience working with interdisciplinary practice and research teams. She is also a director on several non-profit boards, including the College of Registered Nurses of BC and Mount St. Mary Hospital.
Dr. Frances Wong is Vice President of Medical Affairs and Medical Information at BC Cancer Agency. She is involved in matters relating to the professional practice of physicians and is responsible for many technology related projects, such as the Clinical Systems Transformation (CST) project.
Dr. Wong is also a practising radiation oncologist, specializing in the field of breast cancers. She has specific interests in Health Service Delivery research and has engaged in various projects relating to patient navigation and survivorship care planning. Dr. Wong has worked at the BC Cancer Agency Vancouver Centre as a staff radiation oncologist since 1985. In 1994, she was appointed as Department Head of Radiation Oncology and was part of the team that started the BC Cancer Agency Fraser Valley Centre in 1995. She held that position while also serving as the Chief of Department of Oncology at Surrey Memorial Hospital until 2008. Dr. Wong was appointed as the Chief Physician for the Fraser Valley Centre in 2007 and participated in opening the BC Cancer Agency Abbotsford Centre in 2008. She was the Chief Physician for both the BC Cancer Agency Fraser Valley Centre and Abbotsford Centre until 2013 when she was then appointed as Vice President of Medical Affairs for BC Cancer Agency.
Dr. Shallen Letwin is Vice President of Regional Operations at BC Cancer Agency. He is responsible for overseeing all regional operations of the Agency to enable cancer care for the province of British Columbia to be planned provincially and delivered regionally.
Dr. Letwin graduated from the University of Alberta and University of British Columbia with undergraduate and graduate degrees in Pharmacy and has held various positions with pharmacy including working as the Regional Director for Fraser Health. He led a team as the Executive Director, Lower Mainland Pharmacy Services and next as Executive Director, Clinical Operations (Medicine), Abbotsford Regional Hospital and Peace Arch Hospital within Fraser Health. Most recently, he was the Vice President, Community Hospitals and Programs for Fraser Health where he was responsible for the overall clinical operations of acute and community based services in several communities.